IRON
Price
$87.16
Change
-$2.78 (-3.09%)
Updated
Oct 20, 04:59 PM (EDT)
Capitalization
3.13B
17 days until earnings call
Intraday Buy/Sell Signals
ZYME
Price
$18.30
Change
-$0.10 (-0.54%)
Updated
Oct 20, 04:59 PM (EDT)
Capitalization
1.39B
Intraday Buy/Sell Signals
Interact to see
Advertisement

IRON vs ZYME

Header iconIRON vs ZYME Comparison
Open Charts IRON vs ZYMEBanner chart's image
Disc Medicine
Price$87.16
Change-$2.78 (-3.09%)
Volume$35.16K
Capitalization3.13B
Zymeworks
Price$18.30
Change-$0.10 (-0.54%)
Volume$17.62K
Capitalization1.39B
IRON vs ZYME Comparison Chart in %
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRON vs. ZYME commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Hold and ZYME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (IRON: $89.94 vs. ZYME: $18.40)
Brand notoriety: IRON and ZYME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 578% vs. ZYME: 78%
Market capitalization -- IRON: $3.13B vs. ZYME: $1.39B
IRON [@Biotechnology] is valued at $3.13B. ZYME’s [@Biotechnology] market capitalization is $1.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileZYME’s FA Score has 0 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • ZYME’s FA Score: 0 green, 5 red.
According to our system of comparison, both IRON and ZYME are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 4 TA indicator(s) are bullish while ZYME’s TA Score has 4 bullish TA indicator(s).

  • IRON’s TA Score: 4 bullish, 3 bearish.
  • ZYME’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IRON is a better buy in the short-term than ZYME.

Price Growth

IRON (@Biotechnology) experienced а +28.67% price change this week, while ZYME (@Biotechnology) price change was +1.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was +18.12%, and the average quarterly price growth was +72.90%.

Reported Earning Dates

IRON is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRON($3.13B) has a higher market cap than ZYME($1.39B). IRON YTD gains are higher at: 41.861 vs. ZYME (25.683). ZYME has higher annual earnings (EBITDA): -69.77M vs. IRON (-142.42M). IRON has more cash in the bank: 650M vs. ZYME (281M). ZYME has less debt than IRON: ZYME (18.7M) vs IRON (30.9M). ZYME has higher revenues than IRON: ZYME (123M) vs IRON (0).
IRONZYMEIRON / ZYME
Capitalization3.13B1.39B224%
EBITDA-142.42M-69.77M204%
Gain YTD41.86125.683163%
P/E RatioN/AN/A-
Revenue0123M-
Total Cash650M281M231%
Total Debt30.9M18.7M165%
FUNDAMENTALS RATINGS
ZYME: Fundamental Ratings
ZYME
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRONZYME
RSI
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
73%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZYME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MWECX38.610.22
+0.57%
MFS Global Equity C
LMESX38.970.22
+0.57%
ClearBridge Appreciation IS
MECZX54.480.07
+0.13%
AMG GW&K International Small Cap Z
SMFYX42.920.04
+0.09%
American Beacon Stephens Mid-Cap Gr Y
HDQVX18.77-0.04
-0.21%
Janus Henderson International Div S

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with NUVL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+20.95%
NUVL - IRON
54%
Loosely correlated
+2.32%
KMSTF - IRON
54%
Loosely correlated
N/A
IDYA - IRON
51%
Loosely correlated
+5.67%
SYRE - IRON
51%
Loosely correlated
+1.03%
CGON - IRON
51%
Loosely correlated
-0.93%
More

ZYME and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZYME has been loosely correlated with VRDN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ZYME jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYME
1D Price
Change %
ZYME100%
-0.81%
VRDN - ZYME
48%
Loosely correlated
+5.22%
ELVN - ZYME
47%
Loosely correlated
-1.56%
RVMD - ZYME
46%
Loosely correlated
+8.90%
NRIX - ZYME
46%
Loosely correlated
-1.89%
ABEO - ZYME
46%
Loosely correlated
-1.65%
More